Cargando…

Prevalence of medication discrepancies in patients with cirrhosis: a pilot study

BACKGROUND: Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayward, Kelly L., Valery, Patricia C., Cottrell, W. Neil, Irvine, Katharine M., Horsfall, Leigh U., Tallis, Caroline J., Chachay, Veronique S., Ruffin, Brittany J, Martin, Jennifer H., Powell, Elizabeth E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020443/ https://www.ncbi.nlm.nih.gov/pubmed/27618841 http://dx.doi.org/10.1186/s12876-016-0530-4

Ejemplares similares

Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
por: Hayward, Kelly L., et al.
Publicado: (2021)

Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2020)

Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention
por: Hayward, Kelly L., et al.
Publicado: (2019)

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
por: Hayward, Kelly L, et al.
Publicado: (2017)

Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial
por: Hayward, Kelly L., et al.
Publicado: (2017)

Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2022)

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies
por: Hayward, Kelly L, et al.
Publicado: (2020)

Reply
por: Hayward, Kelly L., et al.
Publicado: (2019)

Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)
por: Valery, Patricia C, et al.
Publicado: (2020)

Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study
por: Johnson, Amy L, et al.
Publicado: (2021)

Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM
por: Hayward, Kelly Lee, et al.
Publicado: (2021)

Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: A population-based study
por: Ratnasekera, Isanka U., et al.
Publicado: (2022)

The Patient’s Perspective in Cirrhosis: Unmet Supportive Care Needs Differ by Disease Severity, Etiology, and Age
por: Valery, Patricia C., et al.
Publicado: (2021)

Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians
por: Valery, Patricia C., et al.
Publicado: (2020)

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests
por: Johnson, Amy L., et al.
Publicado: (2021)

Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis
por: Ahn, Sang Bong, et al.
Publicado: (2020)

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
por: Irvine, Katharine M., et al.
Publicado: (2021)

Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

Assessment of health‐related quality of life and health utilities in Australian patients with cirrhosis
por: McPhail, Steven M, et al.
Publicado: (2020)

Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation
por: Gadd, Victoria L., et al.
Publicado: (2016)

Corrigendum: Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics
por: Elangovan, Harendran, et al.
Publicado: (2020)

A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care
por: Patel, PreyaJanubhai, et al.
Publicado: (2018)

Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers
por: Irvine, Katharine M., et al.
Publicado: (2016)

Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study
por: Valery, Patricia C., et al.
Publicado: (2022)

Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes
por: Gracen, Lucy, et al.
Publicado: (2022)

“An Important Part of Who I am”: The Predictors of Dietary Adherence among Weight-Loss, Vegetarian, Vegan, Paleo, and Gluten-Free Dietary Groups
por: Cruwys, Tegan, et al.
Publicado: (2020)

Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers
por: Fagan, Kevin J, et al.
Publicado: (2014)

The Impact of Social Workers in Cirrhosis Care: a Systematic Review
por: Ufere, Nneka N., et al.
Publicado: (2022)

The psychological characteristics of people consuming vegetarian, vegan, paleo, gluten free and weight loss dietary patterns
por: Norwood, R., et al.
Publicado: (2019)

Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)
por: Brain, David, et al.
Publicado: (2020)

Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians
por: Powell, Elizabeth E., et al.
Publicado: (2019)

Disparities in Unmet Needs in Indigenous and Non-Indigenous Australians with Cirrhosis: An Exploratory Study
por: Bernardes, Christina M, et al.
Publicado: (2021)

Geometric Discrepancy
por: Matousek, Jiri
Publicado: (1999)

Masculine Discrepancy Stress, Emotion-Regulation Difficulties, and Intimate Partner Violence
por: Berke, Danielle S., et al.
Publicado: (2016)

Database discrepancies in understanding the burden of mass shootings in the United States, 2013–2020
por: Bridges, Tristan, et al.
Publicado: (2023)

Low Prevalence of Use of Allied Health and Community Services for Patients with Cirrhosis in Australia: A Need for Greater Engagement
por: Powell, Elizabeth E, et al.
Publicado: (2023)

Mesiodistal tooth width and tooth size discrepancies of Yemeni Arabians: A pilot study
por: Al-Gunaid, Talat, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dp0r9qsrpj81oa7t99ngpid9gc